Investors & Media

Investors & Media

About Kiniksa

We are a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from devastating and debilitating diseases with significant unmet medical need. We have built a pipeline of product candidates across various stages of development, currently focused on autoinflammatory and autoimmune diseases.

Stock

Price: Change: Volume:

Oct 19, 2018 9:41 PM EDT

Copyright Nasdaq. Minimum 15 minutes delayed.

Events and Presentations

10/10/18 at
8:00 AM EDT